Donate Today Log In

Clinical Department · Precision Medicine

Heart Health Through
Precision Cardiology

Risk Profiling · Genomics · Metabolomics · Inflammation · Prevention · Pharmacogenomics

Root

Cause Medicine

Multi

Omic Data

100%

Individualized

Board

Certified Standard

Department Overview

Pre·ci·sion
Car·di·ol·o·gy

/ ˈpreSHən ˌkärdēˈäləjē / · noun

noun · clinical cardiology

The integration of multi-omic, genomic, and metabolic profiling with advanced cardiovascular diagnostics — moving beyond population-level lipid thresholds to the molecular and inflammatory root causes of individual heart disease.

Origin

From Latin praecisio (exactness) + Greek kardia (heart) + -logia (study of). The precision cardiology paradigm emerged in the 2010s as genomic sequencing and proteomics revealed that conventional cardiovascular risk scores failed to capture the molecular heterogeneity driving atherosclerosis, arrhythmia, and heart failure at the individual level.

The Precision Cardiology Department at the American Board of Precision Medicine trains clinicians to look beyond the standard lipid panel — integrating lipoprotein subfractionation, coronary calcium scoring, polygenic risk scores, inflammatory biomarkers, and metabolomic signatures into a comprehensive, individualized cardiovascular risk portrait that conventional cardiology cannot provide.

From clonal hematopoiesis and endothelial dysfunction to oxidative stress pathways, gut microbiome-driven TMAO production, and insulin resistance as a cardiometabolic driver, this department equips physicians with the molecular fluency to identify the upstream causes of cardiovascular disease — and to intervene long before a first event occurs.

Heart disease is not a single entity — it is a convergence of genetic predisposition, metabolic dysregulation, chronic inflammation, and environmental exposure. At ABOPM, Precision Cardiology provides the clinical framework to decode that convergence for every patient, individually.

#1

Cause of Death

80%

Preventable Cases

Multi

Omic Risk Profiling

Precision Cardiology Department · ABOPM

Where Cardiovascular Science Meets
Individual Patient Care

The Precision Cardiology Department at ABOPM is redefining heart and vascular care through molecular and genomic insight — training physicians to integrate cardiovascular genomics, advanced biomarkers, imaging phenotyping, and individualized pharmacotherapy into treatment strategies that go far beyond conventional risk models to address each patient's unique cardiac biology.

Cardiovascular Genomics

Advancing clinical application of inherited arrhythmia genetics, cardiomyopathy mutation profiling, familial hypercholesterolemia screening, and pharmacogenomic-guided therapy — enabling cardiologists to move from population-based protocols to molecularly informed, patient-specific treatment.

Clinical Translation

Bridging cardiovascular research and bedside practice — developing board-certified frameworks for biomarker-driven risk stratification, advanced cardiac imaging interpretation, precision heart failure management, and individualized antithrombotic and lipid-lowering strategies.

Physician Education

Building the next generation of precision cardiologists through rigorous board standards, interdisciplinary training, and collaboration across interventional cardiology, electrophysiology, heart failure, vascular medicine, clinical pharmacology, and cardiovascular genomics.

"No two hearts fail the same way. The Precision Cardiology Department at ABOPM trains physicians to look beyond the ECG and the echo — integrating genomics, biomarkers, and molecular phenotyping to understand and treat the cardiovascular disease that is uniquely present in each patient."

American Board of Precision Medicine · Precision Cardiology Department

Become a Member → Support Our Mission → Get Involved →

Precision Cardiology Department · ABOPM

Translating Cardiovascular Genomics
Into Individualized Heart Care

No two hearts fail the same way. Behind every arrhythmia, cardiomyopathy, and atherosclerotic event lies a unique molecular substrate — inherited variants, pharmacogenomic profiles, inflammatory biomarkers, and metabolic signatures that population-based risk models were never designed to capture. Treating the cardiovascular disease that is actually present in each patient, rather than the average patient, is not an aspirational goal — it is the clinical obligation of modern cardiology.

Precision cardiology equips clinicians to move beyond standardized protocols and into molecularly informed cardiovascular care — integrating cardiac genomics, advanced biomarkers, imaging phenotyping, and pharmacogenomics to risk-stratify, diagnose, and treat each patient's heart disease with a specificity that guidelines alone cannot provide.

By mastering precision cardiology, clinicians gain the power to:

01

Decode Each Patient's Cardiac Genome

Move beyond population risk scores to interpret inherited arrhythmia genetics, cardiomyopathy mutation profiles, and familial hypercholesterolemia variants — identifying the molecular substrate driving each patient's cardiovascular disease and its implications for family screening and cascade testing.

02

Apply Advanced Biomarkers with Precision

Use high-sensitivity troponins, novel heart failure biomarkers, inflammatory markers, and multi-marker panels to achieve earlier diagnosis, more accurate risk stratification, and more sensitive monitoring of treatment response across ischemic, structural, and inflammatory cardiac disease.

03

Phenotype Beyond the Echo

Integrate advanced cardiac imaging — strain analysis, cardiac MRI tissue characterization, multimodality phenotyping — with molecular data to identify the specific pathophysiological substrate driving each patient's cardiomyopathy, guiding targeted therapeutic decisions no standard echo can inform.

04

Prescribe with Pharmacogenomic Intelligence

Apply CYP450 and drug transporter pharmacogenomics to individualize antiplatelet therapy, anticoagulation, antiarrhythmic dosing, and statin selection — eliminating preventable adverse drug reactions and optimizing therapeutic efficacy at the molecular level for every cardiac patient.

05

Lead Precision Cardiology at Your Institution

Become the cardiovascular genomics authority and precision cardiology program leader your institution needs — the cardiologist who integrates molecular diagnostics, advanced imaging, and pharmacogenomics into a unified clinical strategy that transforms outcomes for every patient with complex heart disease.

Why Precision Cardiology Certification Is Non-Negotiable

Every heart has a molecular story. The question is, are you equipped to read it?

Patient Outcomes

Genomically and molecularly informed cardiovascular care consistently outperforms population-based protocols — delivering measurably better outcomes in inherited cardiomyopathy, arrhythmia management, heart failure, and atherosclerotic disease through individualized precision strategies.

Future-Ready Practice

Cardiovascular genomics, AI-enhanced imaging phenotyping, wearable-derived biomarkers, and pharmacogenomics-guided prescribing are transforming cardiology — cardiologists board-certified in precision cardiology will define the next standard of care.

Clinical Authority

Board certification in precision cardiology marks you as the cardiovascular genomics and molecular cardiology authority — a cardiologist equipped to lead inherited heart disease programs, multidisciplinary cardiac teams, and institutional precision cardiovascular initiatives.

Cross-Subspecialty Impact

Precision cardiology principles apply across electrophysiology, interventional cardiology, heart failure, vascular medicine, and preventive cardiology — giving you a universal molecular framework to individualize care across every cardiovascular subspecialty.

Active research areas driving precision cardiology forward:

01

Cardiovascular Genomics

Advancing the clinical application of inherited arrhythmia genetics, cardiomyopathy mutation profiling, familial hypercholesterolemia variant detection, and polygenic risk scoring — building the evidence base for genomically informed cardiovascular risk stratification, cascade screening, and molecularly guided therapy selection.

02

Advanced Cardiac Biomarker Research

Developing and validating next-generation cardiovascular biomarker panels — high-sensitivity troponins, novel heart failure markers, inflammatory mediators, and multi-analyte signatures — that achieve earlier diagnosis, more precise risk stratification, and more sensitive treatment monitoring across ischemic, structural, and inflammatory cardiac disease.

03

Multimodality Imaging Phenotyping

Integrating advanced cardiac imaging — strain echocardiography, cardiac MRI tissue characterization, CT-derived fractional flow reserve, and nuclear imaging — with molecular and genomic data to define the specific pathophysiological substrates driving each patient's cardiomyopathy, ischemia, or arrhythmia phenotype.

04

Cardiovascular Pharmacogenomics

Mapping the pharmacogenomic determinants of cardiovascular drug response — CYP2C19 and antiplatelet therapy, SLCO1B1 and statin myopathy, CYP2D6 and antiarrhythmic dosing — to build the clinical frameworks that enable individualized, genotype-guided prescribing across every cardiovascular drug class.

05

Wearable & Digital Biomarker Integration

Establishing clinical validation frameworks for continuous cardiovascular monitoring via wearables, implantable sensors, and digital biomarker platforms — defining the evidence standards, alert thresholds, and clinical decision pathways that translate real-world cardiac data streams into actionable, individualized management strategies.

Precision Cardiology Research · ABOPM

Pushing the Frontier of Molecular Heart Medicine

The precision cardiology revolution is not a future event — it is rewriting cardiovascular care today. Cardiovascular genomics, advanced biomarker science, multimodality imaging phenotyping, and pharmacogenomics-guided prescribing are actively transforming how every heart disease is diagnosed, stratified, and treated at the molecular and individual level.

The ABOPM Precision Cardiology Department positions clinicians at the center of this transformation — equipping them with the cardiovascular genomics literacy, molecular diagnostic frameworks, and board-certified credentials to lead precision heart care across every cardiac subspecialty.

$22B

Precision cardiology market projected by 2030

1 in 3

Inherited cardiomyopathy patients carry an actionable variant

40%

Of cardiac drug responses are pharmacogenomically determined

Explore Blog Topics → Read clinical insights, case studies & precision cardiology updates on our blog

Precision Cardiology Department · ABOPM

Meet Our Leadership

Director of Precision Cardiology

Director

Precision Cardiology

Director of Precision Cardiology Interventional Cardiology Functional Medicine

Sanjay Bhojraj, MD

Interventional Cardiologist · Precision & Functional Medicine Leader · Creator of Well12

"A visionary leader in cardiovascular health — merging interventional cardiology with precision and functional medicine to address root causes of disease and empower patients to transform their health from the inside out."

Dr. Sanjay Bhojraj is a visionary leader in cardiovascular health, merging interventional cardiology with precision and functional medicine. As one of the few cardiologists certified in Functional Medicine through the Cleveland Clinic-affiliated Institute of Functional Medicine, he reimagines heart health by addressing the root causes of disease rather than managing downstream symptoms.

His practice employs advanced cardiac imaging, comprehensive lipid analysis, and "omics" technologies — genomics, proteomics, and metabolomics — to assess individual cardiovascular risk well beyond population-based models. This approach enables precise diagnostics and bespoke treatment plans that integrate longevity, functional, and conventional medicine for lasting health transformation.

Dr. Bhojraj is the creator of Well12, a 10-week wellness program promoting lasting lifestyle changes through nutrition, sleep, movement, and mindset, rooted in functional medicine and the gut-brain connection. A dynamic educator and speaker, he is establishing educational programs to teach physicians how to apply functional and precision medicine in practice and take on leadership roles in the MedTech industry. As a devoted husband and father of triplet daughters, his personal journey toward optimal health informs his mission to inspire others to achieve lasting well-being.

IFM

Functional Medicine Certified

Well12

Wellness Program Creator

3

Omics Modalities in Practice

Connect on LinkedIn

Faculty Members

Our faculty roster is growing — announcements coming soon.

Coming Soon

Faculty position open

Coming Soon

Faculty position open

Coming Soon

Faculty position open

Coming Soon

Faculty position open

Think you're the right fit for a faculty position?

Get Involved →

Genomics Department · ABOPM

Shaping the Future
of Precision Medicine

As precision medicine continues to evolve, genomics will play an increasingly central role in redefining how disease is understood, predicted, and treated at the molecular level.

The Genomics Department at ABOPM remains committed to advancing this field through scientific leadership, clinical innovation, and collaborative discovery. Together with our global community of physicians and researchers, we are helping shape the future of next-generation healthcare.

Explore Certification → Get Involved

Featured Insights

Insights Shaping
Precision Medicine

Explore ABOPM perspectives on genomics, multi-omics, systems thinking, clinical innovation, and the future of physician leadership in precision medicine.

Multi-Omics Clinical Innovation Precision Prevention Physician Leadership

Liquid Biopsy and Early Cancer Detection: Promise and Limitations

Liquid biopsy is transforming cancer detection through minimally invasive genomic testing, offering new opportunities for earlier diagnosis and monitoring. ...more

Precision Oncology

June 05, 2026•9 min read

Polygenic Risk Scores and the Genomic Data Gap: Promise, Limitations, and Equity in Precision Medicine

Polygenic risk scores may transform disease prediction, but gaps in genomic diversity continue to limit equity, accuracy, and access in precision medicine across global populations. ...more

Population Precision

May 26, 2026•9 min read

Artificial Intelligence in Precision Medicine

Artificial intelligence is reshaping precision medicine by improving diagnostics, predicting treatment response, and enabling more personalized, data-driven healthcare strategies. ...more

On the Frontier

May 20, 2026•9 min read